We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$20.2B
AUM Growth
+$1.12B
Cap. Flow
+$1.5B
Cap. Flow %
7.39%
Top 10 Hldgs %
21.52%
Holding
2,502
New
219
Increased
1,362
Reduced
773
Closed
107

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Financials 7.93%
3 Industrials 5.63%
4 Healthcare 5.55%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVOV icon
676
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.34B
$3.39M 0.02%
33,201
-2,095
-6% -$220K
HYEM icon
677
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
$3.39M 0.02%
171,488
+4,248
+3% +$85.1K
LULU icon
678
lululemon athletica
LULU
$13B
$3.38M 0.02%
22,169
+2,041
+10% +$366K
CAVA icon
679
CAVA Group
CAVA
$7.22B
$3.38M 0.02%
41,908
+402
+1% +$29.3K
CALF icon
680
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.59B
$3.37M 0.02%
75,457
-53,257
-41% -$2.42M
BN icon
681
Brookfield
BN
$102B
$3.35M 0.02%
82,847
-2,660
-3% -$118K
SPXX icon
682
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$331M
$3.35M 0.02%
+208,680
New +$3.66M
PPA icon
683
Invesco Aerospace & Defense ETF
PPA
$8.27B
$3.35M 0.02%
20,221
+1,809
+10% +$316K
EDV icon
684
Vanguard World Funds Extended Duration ETF
EDV
$3.3B
$3.34M 0.02%
51,498
+4,383
+9% +$290K
UTHR icon
685
United Therapeutics
UTHR
$26.3B
$3.33M 0.02%
5,510
+2,072
+60% +$1.03M
PTRB icon
686
PGIM Total Return Bond ETF
PTRB
$1.08B
$3.33M 0.02%
80,289
+73,211
+1,034% +$3.08M
CNQ icon
687
Canadian Natural Resources
CNQ
$96.9B
$3.32M 0.02%
68,124
+13,183
+24% +$542K
IBB icon
688
iShares Biotechnology ETF
IBB
$9.31B
$3.31M 0.02%
19,624
+413
+2% +$70.6K
GSK icon
689
GSK
GSK
$103B
$3.31M 0.02%
60,115
-33,190
-36% -$1.8M
IJS icon
690
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$3.3M 0.02%
27,920
+1,760
+7% +$213K
HLI icon
691
Houlihan Lokey
HLI
$9.68B
$3.3M 0.02%
22,976
-363
-2% -$59.7K
ACWX icon
692
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$3.29M 0.02%
48,067
+34,143
+245% +$2.41M
PREF icon
693
Principal Spectrum Preferred Securities Active ETF
PREF
$1.77B
$3.29M 0.02%
175,575
+71,788
+69% +$1.37M
CAH icon
694
Cardinal Health
CAH
$53.4B
$3.28M 0.02%
15,563
+2,299
+17% +$495K
MC icon
695
Moelis & Co
MC
$4.98B
$3.28M 0.02%
57,443
+4,452
+8% +$289K
PCAR icon
696
PACCAR
PCAR
$69.6B
$3.27M 0.02%
28,307
-2,603
-8% -$315K
FSK icon
697
FS KKR Capital
FSK
$2.98B
$3.26M 0.02%
321,034
-33,673
-9% -$421K
BUD icon
698
AB InBev
BUD
$158B
$3.23M 0.02%
46,688
-286
-0.6% -$20.6K
PFGC icon
699
Performance Food Group
PFGC
$17.5B
$3.23M 0.02%
37,339
+8,905
+31% +$814K
EFX icon
700
Equifax
EFX
$20.3B
$3.23M 0.02%
17,852
+1,112
+7% +$221K

Similar funds

&Partners's Q1 2026 Portfolio in Review

As of Q1 2026, &Partners held 2,502 positions worth $20.2B, up 5.8% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

&Partners deployed $1.5B of net new capital in Q1 2026, opening 219 new positions and adding to 1,362 existing holdings. Its largest new stake was First Trust Nasdaq Transportation ETF: 367,478 shares worth $14M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Nextpower Inc, an estimated $27.5M trimmed.

  • &Partners's largest Q1 2026 buy was First Trust Nasdaq Transportation ETF: 367,478 shares worth $14M.
  • &Partners added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $77.2M increase.
  • &Partners's biggest Q1 2026 reduction was Nextpower Inc, cutting an estimated $27.5M.
  • &Partners fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $2.96M.
  • &Partners's ten largest holdings make up 22% of its $20.2B portfolio in Q1 2026.
  • &Partners opened 219 new positions and closed 107 in Q1 2026.
  • &Partners's portfolio value rose 5.8% quarter-over-quarter to $20.2B.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.